1. Turgut AT, Vikram VS. Prostate carcinoma:
evaluation using transrectal sonography. InGeneral
Methods and Overviews, Lung Carcinoma and
Prostate Carcinoma 2008 (pp. 499-520). Springer,
Dordrecht.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global
cancer statistics, 2002. CA: a cancer journal for
clinicians. 2005 Mar;55(2):74-108.
3. Sadjadi A, Nooraie M, Ghorbani A,
Alimohammadian M, Zahedi MJ, DarvishMoghadam S, Fakheri H, Babai M, Semnani S,
Mansour-Ghanaei F, Mohagheghi MA. The
incidence of prostate cancer in Iran: results of a
population-based cancer registry. Archives of
Iranian medicine. 2007;10(4):481-5.
4. Andriole GL, Crawford ED, Grubb III RL, Buys
SS, Chia D, Church TR, Fouad MN, Gelmann EP,
Kvale PA, Reding DJ, Weissfeld JL. Mortality
results from a randomized prostate-cancer
screening trial. New England Journal of Medicine.
2009 Mar 26;360(13):1310-9.
5. Grönberg H. Prostate cancer epidemiology. The
Lancet. 2003 Mar 8;361(9360):859-64.
6. Howlader N. SEER Cancer Statistics Review,
1975-2008, National Cancer Institute, Bethesda,
MD. http://seer. cancer. gov/csr/1975_2008/, based
on November 2010 SEER data submission, posted
to the SEER web site. 2011.
7. Ingles SA, Coetzee GA, Ross RK, Henderson BE,
Kolonel LN, Crocitto L, Wang W, Haile RW.
Association of prostate cancer with vitamin D
receptor haplotypes in African-Americans. Cancer
research. 1998 Apr 15;58(8):1620-3.
8. Parker PM, Rice KR, Sterbis JR, Chen Y, Cullen J,
McLeod DG, Brassell SA. Prostate cancer in men
less than the age of 50: a comparison of race and
outcomes. Urology. 2011 Jul 1;78(1):110-5.
9. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T,
Digweed M, D'Andrea AD, Wang ZQ, Jasin M.
Human Fanconi anemia monoubiquitination
pathway promotes homologous DNA repair.
Proceedings of the National Academy of Sciences.
2005 Jan 25;102(4):1110-5.
10. Bennett CL, Ferreira MR, Davis TC, Kaplan J,
Weinberger M, Kuzel T, Seday MA, Sartor O.
Relation between literacy, race, and stage of
presentation among low-income patients with
prostate cancer. Journal of Clinical Oncology. 1998
Sep;16(9):3101-4.
11. Terris MK, Haney DJ, Johnstone IM, McNeal JE,
Stamey TA. Prediction of prostate cancer volume
using prostate-specific antigen levels, transrectal
ultrasound, and systematic sextant biopsies.
Urology. 1995 Jan 1;45(1):75-80.
12. Pallwein L, Mitterberger M, Pinggera G, Aigner F,
Pedross F, Gradl J, Pelzer A, Bartsch G, Frauscher
F. Sonoelastography of the prostate: comparison
with systematic biopsy findings in 492 patients.
European journal of radiology. 2008 Feb
1;65(2):304-10.
13. Ou Y, Shen D, Zeng J, Sun L, Moul J, Davatzikos
C. Sampling the spatial patterns of cancer:
Optimized biopsy procedures for estimating
prostate cancer volume and Gleason Score. Medical
image analysis. 2009 Aug 1;13(4):609-20.
14. Byar DP, Mostofi FK, Veterans Administration
Cooperative Urological Research Group.
Carcinoma of the prostate: prognostic evaluation of
certain pathologic features in 208 radical
prostatectomies. Cancer. 1972 Jul;30(1):5-13.
15. Cheng WS, Frydenberg M, Bergstralh EJ, LarsonKeller JJ, Zincke H. Radical prostatectomy for
pathologic stage C prostate cancer: influence of
pathologic variables and adjuvant treatment on
disease outcome. Urology. 1993 Sep 1;42(3):283-
91.
16. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC,
Billebaud T, Delmas V, Meulemans A, Toublanc
M, Boccon-Gibod L. Systematic biopsies
accurately predict extracapsular extension of
prostate cancer and persistent/recurrent detectable
PSA after radical prostatectomy. Urology. 1994
Sep 1;44(3):371-6.
17. Mcneal J, Kindrachuk R, Freiha F, Bostwick D,
Redwine E, Stamey T. Patterns of progression in
prostate cancer. The Lancet. 1986 Jan
11;327(8472):60-3.
18. Hering F, Rist M, Roth J, Mihatsch M, Rutishauser
G. Does microinvasion of the capsule and/or
micrometastases in regional lymph nodes influence disease‐free survival after radical prostatectomy?.
British journal of urology. 1990 Aug;66(2):176-81.
19. Middleton RG, Smith Jr JA. Radical prostatectomy
for stage B2 prostatic cancer. The Journal of
urology. 1982 Apr 1;127(4):702-3.
20. Catalona WJ, Fleischmann J, Menon M. Pelvic
lymph node status as predictor of extracapsular
tumor extension in clinical stage B prostatic cancer.
The Journal of urology. 1983 Feb 1;129(2):327-9.
21. Badalament RA, Craig MM, Peller PA, Young DC,
Bahn DK, Kochie P, O'Dowd GJ, Veltri RW. An
algorithm for predicting nonorgan confined prostate
cancer using the results obtained from sextant core
biopsies with prostate specific antigen level. The
Journal of urology. 1996 Oct;156(4):1375-80.
22. Bostwick DG, Wheeler TM, Blute M, Barrett DM,
MacLennan GT, Sebo TJ, Scardino PT, Humphrey
PA, M'liss AH, Fradet Y, Miller GJ. Optimized
microvessel density analysis improves prediction of
cancer stage from prostate needle biopsies.
Urology. 1996 Jul 1;48(1):47-57.
23. Koh H, Kattan MW, Scardino PT, Suyama K, Maru
N, Slawin K, Wheeler TM, Ohori M. A nomogram
to predict seminal vesicle invasion by the extent
and location of cancer in systematic biopsy results.
The Journal of urology. 2003 Oct;170(4 Part
1):1203-8.
24. Tsuzuki T, Hernandez DJ, Aydin H, Trock B,
Walsh PC, Epstein JI. Prediction of extraprostatic
extension in the neurovascular bundle based on
prostate needle biopsy pathology, serum prostate
specific antigen and digital rectal examination. The
Journal of urology. 2005 Feb;173(2):450-3.
25. GRAEFEN M, HAESE A, PICHLMEIER U,
HAMMERER PG, NOLDUS J, BUTZ K,
ERBERSDOBLER A, HENKE RP, MICHL U,
FERNANDEZ S, HULAND H. A validated
strategy for side specific prediction of organ
confined prostate cancer: a tool to select for nerve
sparing radical prostatectomy. The Journal of
urology. 2001 Mar;165(3):857-63.
26. Wang L, Hricak H, Kattan MW, Chen HN,
Kuroiwa K, Eisenberg HF, Scardino PT. Prediction
of seminal vesicle invasion in prostate cancer:
incremental value of adding endorectal MR
imaging to the Kattan nomogram. Radiology. 2007
Jan;242(1):182-8.
27. Villers AA, McNeal JE, Redwine EA, Freiha FS,
Stamey TA. Pathogenesis and biological
significance of seminal vesicle invasion in prostatic
adenocarcinoma. The Journal of urology. 1990
Jun;143(6):1183-7.
28. Soylu FN, Peng Y, Jiang Y, Wang S, SchmidTannwald C, Sethi I, Eggener S, Antic T, Oto A.
Seminal vesicle invasion in prostate cancer:
evaluation by using multiparametric endorectal MR
imaging. Radiology. 2013 Jun;267(3):797-806.
29. Epstein JI, Carmichael M, Walsh PC.
Adenocarcinoma of the prostate invading the
seminal vesicle: definition and relation of tumor
volume, grade and margins of resection to
prognosis. The Journal of urology. 1993 May;149(5
Part 1):1040-5.
30. Epstein JI, Lecksell K, Carter HB. Prostate cancer
sampled on sextant needle biopsy: significance of
cancer on multiple cores from different areas of the
prostate. Urology. 1999 Aug 1;54(2):291-4.
31. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS,
Chang SS, Cookson MS. Percent of cancer in the
biopsy set predicts pathological findings after
prostatectomy. The Journal of urology. 2002
May;167(5):2032-6.
32. Poulos CK, Daggy JK, Cheng L. Prostate needle
biopsies: multiple variables are predictive of final
tumor volume in radical prostatectomy specimens.
Cancer: Interdisciplinary International Journal of
the American Cancer Society. 2004 Aug
1;101(3):527-32.
33. Magers MJ, Zhan T, Udager AM, Wei JT, Tomlins
SA, Wu AJ, Kunju LP, Lew M, Feng FY, Hamstra
DA, Siddiqui J. Clinicopathologic characteristics of
anterior prostate cancer (APC), including
correlation with previous biopsy pathology.
Medical Oncology. 2015 Nov;32(11):1-1.
34. Koppie TM, Bianco Jr FJ, Kuroiwa K, Reuter VE,
Guillonneau B, Eastham JA, Scardino PT. The
clinical features of anterior prostate cancers. BJU
international. 2006 Dec;98(6):1167.
35. Bostwick DG, Cheng L. Neoplasms of the
prostate.In:Cheng L, Maclennan GT, Bostwick
DG.Urologic surgical pathology. 4th
ed.Philadelphia: Elsevier;2020:510-511.
36. Nishikimi T, Tsuzuki T, Oohashi T, Yamauchi Y,
Ishida R, Yamada H, Yokoi K, Kobayashi H.
COMPARISON LOCALIZATION RESULTS
BASED ON PROSTATE BIOPSY SPECIMENS
WITH RESULTS BASED ON RADICAL
PROSTATECTOMY SPECIMENS IN
PROSTATE CANCER. Nihon Hinyokika Gakkai
zasshi. The japanese journal of urology. 2016 Jan
1;107(2):87-92.
37. Tavolaro S, Mozer P, Roupret M, Comperat E,
Rozet F, Barret E, Drouin S, Vaessen C, Lucidarme
O, Cussenot O, Boudghène F. Transition zone and
anterior stromal prostate cancers: evaluation of
discriminant location criteria using multiparametric
fusion-guided biopsy. Diagnostic and interventional
imaging. 2018 Jun 1;99(6):403-11.
)